Medicinal Marijuana Association

FEBRUARY 12, 2024

Start by defining the purpose of your event, whether it’s educational, recreational, or advocacy-focused. Collect feedback from participants to improve future events and build a stronger community around cannabis education and advocacy. Choose a suitable venue that aligns with the tone and goals of your event.

Advocacy 52

Advocacy Education Events Environment 52

MMJ Recs

MARCH 6, 2024

Throughout this exploration, you’ll find practical information to help you understand the changing landscape of medical marijuana and its potential benefits for you and your community. As you navigate this landscape, gain insights into how medical marijuana impacts healthcare practices, perceptions, and societal norms.

Marijuana 52

Marijuana Chronic Pain Patients Treatment 52

MMJ Recs

DECEMBER 22, 2023

The AIDS epidemic in the 1980s brought attention to the potential benefits of marijuana in alleviating symptoms such as nausea and appetite loss associated with the disease and its treatment. This prompted some states to take the first steps toward legalizing medical marijuana.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Peninsula Alternative Health

MARCH 1, 2018

ASA works with a grassroots base of more than 50,000 members using public education and direct advocacy to affect national change. The physician advocate outlines practice risks and benefits, educational requirements, compliance issues, and more for those interested in studying this alternative treatment. Based in Washington, D.C.

Treatment 40

Treatment Education Advocacy Access 40

Peninsula Alternative Health

MARCH 1, 2018

ASA works with a grassroots base of more than 50,000 members using public education and direct advocacy to affect national change. The physician advocate outlines practice risks and benefits, educational requirements, compliance issues, and more for those interested in studying this alternative treatment. Based in Washington, D.C.

Treatment 40

Treatment Education Advocacy Access 40

MMJ Recs

FEBRUARY 3, 2024

In Philadelphia, patients must be diagnosed with specific medical conditions to be eligible for medical cannabis treatment. This card serves as official documentation, attesting to a patient’s eligibility for medical marijuana treatment.

Legislation 52

Legislation Law Marijuana Dispensary 52

Veriheal

JANUARY 24, 2023

With its abundance of medicinal properties and non-addictive nature, why does marijuana remain an untapped resource for researchers wanting to find treatments for debilitating chronic diseases like Parkinson’s? As a result, cannabis advocacy groups urged the agency to recognize cannabis’ medicinal value and treat it equally.

DEA 98

DEA Treatment Medicine Pets 98

Cannabis Law Report

MARCH 12, 2022

Washington legislators fund $200,000 USD for a Psilocybin Wellness Workgroup to research and write a report that will inform a pathway for future legislation. ? It will also gather the latest science and information on best practices from both health care professionals and current practitioners. March 12, 2022. ?

Medicine 52

Medicine Advocacy Legislation Treatment 52

Veriheal

FEBRUARY 21, 2023

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. Why Do MMJ Patients Use Cannabis?

Access 98

Access Patients Chronic Pain Conditions 98

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. Support for Patient Well-Being The availability of medical marijuana in local communities fosters an environment of support for patients seeking alternative treatments.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

APRIL 21, 2022

MAPS PBC is pioneering new forms of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for post-traumatic stress disorder (PTSD). MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

Cannabis Law Report

AUGUST 25, 2021

“Addiction is an all-too common health condition but it’s one that often develops over time and is harder to recognize in oneself than other illnesses—especially early in its progression—which is why information, education and motivation are so important to taking those first steps toward any kind of change.”.

Education 105

Education Programs Research and Development Treatment 105

The Cannigma

MAY 18, 2023

This marked a significant step toward recognizing the therapeutic potential of cannabis-based treatments. The availability and legality of CBD products may vary, and it is advisable to consult local authorities or legal experts for accurate and up-to-date information. Is it legal to grow cannabis in Nepal?

Law 52

Law Cultivation Advocacy Consumption 52

MMJ Recs

OCTOBER 13, 2023

For patients seeking access to this valuable form of treatment, it’s essential to understand the complex web of regulations, legal requirements, and rights surrounding medical marijuana in the Golden State. The list of qualifying conditions can change, so it’s essential to stay informed about the latest updates.

Patients 52

Patients Law Cultivation Dispensary 52

SpeedWeed

SEPTEMBER 17, 2021

The funding will allow MAPS Public Benefit Corporation (MAPS PBC) to activate a team to evaluate the scope of the lack of resources needed for TBI treatment. . Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. announced its commitment to fund $1.5

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

United Patients Group

APRIL 14, 2023

With more research being conducted on the effects of cannabis on appetite, we may see new treatments and therapies developed that utilize this plant’s unique properties. Find Out More United Patients Group is committed to providing reliable and accurate information about medical cannabis and its potential benefits and risks.

THC 52

THC Strains Research and Development Patients 52

MMJ Recs

MARCH 2, 2024

This guide aims to demystify the process, offering practical advice and insights to help patients make informed decisions. Dispensaries prioritize patient education, providing information on various strains, consumption methods, and dosage recommendations. Ask questions to gain insights and make informed decisions about products.

Dispensary 52

Dispensary Patients Marijuana Education 52

Cannabis Law Report

JUNE 6, 2022

As more states legalize cannabis products, either for medical use, recreational use, or both, we have seen a need within the healthcare industry for credible information that can help clinicians guide patients toward safe and effective cannabis use,” says Wes Crews , Chief Executive of TRC Healthcare.

Education 52

Education Research and Development Pharmaceutical Programs 52

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

JULY 19, 2021

For more information on the board, click here. For more information on this board, click here. Cannabis Public Health Advisory Board. The 21-person Cannabis Public Health Advisory Council is an expert advisory council to the CCA. Source: [link].

Legalization 105

Legalization Research and Development Safety Advocacy 105

NORML

FEBRUARY 13, 2019

Passage of The Veterans Medical Marijuana Safe Harbor Act ends this discrimination against veterans and prevents sanctions against VA doctors who wish to recommend medical cannabis treatment to their patients. Click here to send a message to your federal lawmakers now! A copy of the bill is available here.

Legislation 230

Legislation Access Chronic Pain Marijuana 230

Cannabis Law Report

JANUARY 12, 2022

This level of understanding can inform best practices, improve outcomes, and contribute to sensible policy-making both in Oregon and beyond. We see our role as being ethical guardians of information in this emerging field of healing,” says Maya CEO David Champion. “As ABOUT THE NATIONAL PSYCHEDELICS ASSOCIATION.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Cannabis Law Report

OCTOBER 14, 2021

formerly the Canadian Association of Retired Persons), Canada’s largest advocacy association for Canadians As We Age. Understanding the utility of medical cannabis is increasingly important to older Canadians for the treatment of conditions including chronic pain, anxiety and lack of sleep. ’s advocacy. Most C.A.R.P.

Advocacy 52

Advocacy Research and Development Chronic Pain Pharmaceutical 52

Cannabis Law Report

AUGUST 19, 2021

Under the licensing agreements, Cookies will also have a “Cookies Corner,” a store-within-a-store concept, at all of TerrAscend’s Apothecarium Alternative Treatment Centers in New Jersey. For more information about TerrAscend, visit www.terrascend.com. Forward Looking Information. About TerrAscend.

Cultivation 105

Cultivation Seed-To-Sale Conditions Business 105

NORML

JANUARY 28, 2020

Those who face arrest or even summary offenses for possession are often made to undergo questionable and expensive drug treatment programs to avoid further prosecution. For more information, please contact Jeff Riedy, 610-533-0906, lehighvnorml@gmail.com or NORML Regional Organizer Chris Goldstein 609 726 6030.

Marijuana 286

Marijuana Data Decriminalization Policy 286

Cannabis Law Report

JULY 28, 2021

Through this partnership, we will be able to offer our members and supporters a trusted resource to learn about the latest medical cannabis research, benefits, and treatment options available for patients.”. For more information, please visit: [link].

Access 105

Access Patients Education Treatment 105

CannaMD

SEPTEMBER 9, 2019

He is a board member of the advocacy group Doctors For Cannabis Regulation and spent two years as an Associate Director of the Massachusetts Physician Health Service helping physicians with addiction and mental health issues. Looking for more information? Harvard: Marijuana Opinions. Finding Experienced Medical Marijuana Doctors.

Chronic Pain 62

Chronic Pain Marijuana Nerve Pain Advocacy 62

Cannabis Law Report

DECEMBER 9, 2021

After working with Carter’s neurologist to balance TXOG’s medicine with other treatments, they noticed a difference in seizure reduction as well as improved behavioral control and sleep. For more information, visit www.texasoriginal.com. We remain committed to advancing safe, legal access to this powerful medicine. Emma Chase.

Conditions 52

Conditions Patients Sleep Medicine 52

WeedAdvisor

APRIL 9, 2019

The precarious collection of customer information appears to be an issue once more at Toronto’s Hunny Pot dispensary, according to Global News. The brick and mortar cannabis store – which enjoyed roaring success when it opened its doors on April 1 st – now faces scrutiny over their treatment of customer IDs. However, the U.S.

Collective 40

Collective Advocacy Data Cannabis 40

Cannabis Law Report

JUNE 29, 2021

(“Ava Pathways”), remains focused on neuroplasticity and alternative ways to treat common and debilitating medical conditions such as depression, anxiety, PTSD, and substance use disorder, through the use of psychedelic-based treatments. For further information: Matthew Watters, CEO, and Director. Phone: (604) 687-2038.

CBD 95

CBD Events Recreational Cannabinoids 95

NORML

MAY 24, 2019

At the same time, the bill would redirect tax revenue from a legal industry towards various programs that redress harms from the War on Drugs, while also increasing and improving public education and treatment programs geared towards responsible use, reducing overdoses, and saving lives. percent to 17.8 percent in 2016.

Marijuana 103

Marijuana Education Advocacy Legislation 103

Cannabis Law Report

SEPTEMBER 16, 2022

“This campaign aims to increase awareness and understanding of DoD prohibited substances, provide educational information on the topic of marijuana prohibited substances, and highlight the resources that are available,” said Kim Harris, Eglin’s Civilian Health Promotions Services coordinator. Source: [link].

Hemp 52

Hemp CBD Marijuana Wellness and Beauty 52

CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains 69

Strains Epilepsy Advocacy Medicine 69

Otherside Farms

JANUARY 25, 2019

Smith was diagnosed with inoperable liver cancer in 2009 and sought treatment from the internationally known Cedars-Sinai in L.A. Smith’s cancer was in remission until just recently, but now he is scheduled to undergo radiation treatments in a few days. Sixty-three-year-old medical marijuana patient Norman B.

Patients 76

Patients Clinical Trials Marijuana Policy 76

Cannabis Law Report

NOVEMBER 17, 2021

AUSTIN, Texas–(BUSINESS WIRE)– Texas Original Compassionate Cultivation (TXOG), Texas’ leading medical cannabis provider, continues its patient-centric advocacy and awareness series, Advocates for Cannabis in Texas (ACT), to observe National Epilepsy Awareness Month. For more information, visit www.texasoriginal.com.

Patients 52

Patients Epilepsy Medicine Advocacy 52

Cannabis Law Report

NOVEMBER 29, 2021

CRIC represents the highest standards, ethics and best practices; provides effective promotion and advocacy of the industry; serves as a source of information and thought leadership; and is a forum for collective industry action. Quotes from participating organizations: Name and Contact Information.

Research and Development 52

Research and Development Topical Programs Business 52

Cannabis Law Report

MAY 25, 2022

The plaintiff, Cristina Barbuto, used small quantities of medicinal marijuana as treatment for her Crohn’s disease. Barbuto informed her to-be supervisor at ASM that she was a qualifying medical marijuana patient under Massachusetts law, adding that she did not take the medical marijuana before work or at work.

Policy 52

Policy Safety Law Patients 52